HCA Healthcare (NYSE:HCA), a prominent player in the healthcare sector, known for its extensive network of hospitals and healthcare facilities, is preparing to release its quarterly earnings on January 27, 2026. Analysts are keenly observing the expected financial performance, with an anticipated earnings per share (EPS) of $7.36, and projected revenue of approximately $19.67 billion.
The upcoming earnings report for the quarter ended December 2025 is expected to show significant growth. Analysts predict an EPS of $7.36, marking an 18.3% increase from the same period last year. Revenue is projected to reach $19.67 billion, a 7.4% year-over-year increase. This growth is driven by higher admissions, increased occupancy, and rising revenue per admission.
Despite the positive outlook, HCA faces challenges such as higher operating expenses and supply-cost inflation. Additionally, a decrease in outpatient surgeries could impact overall results. However, the earnings estimate has remained stable over the past week, indicating confidence in the company's performance despite these pressures.
HCA's financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of approximately 17.91, reflecting the market's valuation of its earnings. Its price-to-sales ratio is about 1.44, and the enterprise value to sales ratio is around 2.05, indicating how the market values the company in relation to its sales.
The company's financial health is further highlighted by its earnings yield of about 5.58% and a negative debt-to-equity ratio of -8.69, suggesting a higher level of debt compared to its equity. HCA's current ratio of approximately 0.85 indicates its ability to cover short-term liabilities with short-term assets, a crucial factor for investors assessing the company's liquidity.
